Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.
Hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that mediates the adaptation of tumor cells and tissues to the hypoxic microenvironment, has attracted considerable interest as a potential therapeutic target. Tirapazamine (TPZ), a well-characterized bioreductive anticancer ag...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC2976688?pdf=render |
| _version_ | 1817981870807187456 |
|---|---|
| author | Jun Zhang Ji Cao Qinjie Weng Rui Wu Yan Yan Hui Jing Hong Zhu Qiaojun He Bo Yang |
| author_facet | Jun Zhang Ji Cao Qinjie Weng Rui Wu Yan Yan Hui Jing Hong Zhu Qiaojun He Bo Yang |
| author_sort | Jun Zhang |
| collection | DOAJ |
| description | Hypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that mediates the adaptation of tumor cells and tissues to the hypoxic microenvironment, has attracted considerable interest as a potential therapeutic target. Tirapazamine (TPZ), a well-characterized bioreductive anticancer agent, is currently in Phase II and III clinical trials. A major aspect of the anticancer activity of TPZ is its identity as a tumor-specific topoisomerase IIα inhibitor. In the study, for the first time, we found that TPZ acts in a novel manner to inhibit HIF-1α accumulation driven by hypoxia or growth factors in human cancer cells and in HepG2 cell-derived tumors in athymic nude mice. We investigated the mechanism of TPZ on HIF-1α in HeLa human cervical cancer cells by western blot analysis, reverse transcription-PCR assay, luciferase reporter assay and small interfering RNA (siRNA) assay. Mechanistic studies demonstrated that neither HIF-1α mRNA levels nor HIF-1α protein degradation are affected by TPZ. However, TPZ was found to be involved in HIF-1α translational regulation. Further studies revealed that the inhibitory effect of TPZ on HIF-1α protein synthesis is dependent on the phosphorylation of translation initiation factor 2α (eIF2α) rather than the mTOR complex 1/eukaryotic initiation factor 4E-binding protein-1 (mTORC1/4E-BP1) pathway. Immunofluorescence analysis of tumor sections provide the in vivo evidences to support our hypothesis. Additionally, siRNA specifically targeting topoisomerase IIα did not reverse the ability of TPZ to inhibit HIF-1α expression, suggesting that the HIF-1α inhibitory activity of TPZ is independent of its topoisomerase IIα inhibition. In conclusion, our findings suggest that TPZ is a potent regulator of HIF-1α and provide new insight into the potential molecular mechanism whereby TPZ serves to reduce HIF-1α expression. |
| first_indexed | 2024-04-13T23:11:39Z |
| format | Article |
| id | doaj.art-551a4588670e40d7bf3812c20bc35e90 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-04-13T23:11:39Z |
| publishDate | 2010-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-551a4588670e40d7bf3812c20bc35e902022-12-22T02:25:32ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-01-01511e1391010.1371/journal.pone.0013910Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway.Jun ZhangJi CaoQinjie WengRui WuYan YanHui JingHong ZhuQiaojun HeBo YangHypoxia-inducible factor 1 (HIF-1), a heterodimeric transcription factor that mediates the adaptation of tumor cells and tissues to the hypoxic microenvironment, has attracted considerable interest as a potential therapeutic target. Tirapazamine (TPZ), a well-characterized bioreductive anticancer agent, is currently in Phase II and III clinical trials. A major aspect of the anticancer activity of TPZ is its identity as a tumor-specific topoisomerase IIα inhibitor. In the study, for the first time, we found that TPZ acts in a novel manner to inhibit HIF-1α accumulation driven by hypoxia or growth factors in human cancer cells and in HepG2 cell-derived tumors in athymic nude mice. We investigated the mechanism of TPZ on HIF-1α in HeLa human cervical cancer cells by western blot analysis, reverse transcription-PCR assay, luciferase reporter assay and small interfering RNA (siRNA) assay. Mechanistic studies demonstrated that neither HIF-1α mRNA levels nor HIF-1α protein degradation are affected by TPZ. However, TPZ was found to be involved in HIF-1α translational regulation. Further studies revealed that the inhibitory effect of TPZ on HIF-1α protein synthesis is dependent on the phosphorylation of translation initiation factor 2α (eIF2α) rather than the mTOR complex 1/eukaryotic initiation factor 4E-binding protein-1 (mTORC1/4E-BP1) pathway. Immunofluorescence analysis of tumor sections provide the in vivo evidences to support our hypothesis. Additionally, siRNA specifically targeting topoisomerase IIα did not reverse the ability of TPZ to inhibit HIF-1α expression, suggesting that the HIF-1α inhibitory activity of TPZ is independent of its topoisomerase IIα inhibition. In conclusion, our findings suggest that TPZ is a potent regulator of HIF-1α and provide new insight into the potential molecular mechanism whereby TPZ serves to reduce HIF-1α expression.http://europepmc.org/articles/PMC2976688?pdf=render |
| spellingShingle | Jun Zhang Ji Cao Qinjie Weng Rui Wu Yan Yan Hui Jing Hong Zhu Qiaojun He Bo Yang Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. PLoS ONE |
| title | Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. |
| title_full | Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. |
| title_fullStr | Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. |
| title_full_unstemmed | Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. |
| title_short | Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. |
| title_sort | suppression of hypoxia inducible factor 1α hif 1α by tirapazamine is dependent on eif2α phosphorylation rather than the mtorc1 4e bp1 pathway |
| url | http://europepmc.org/articles/PMC2976688?pdf=render |
| work_keys_str_mv | AT junzhang suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway AT jicao suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway AT qinjieweng suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway AT ruiwu suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway AT yanyan suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway AT huijing suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway AT hongzhu suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway AT qiaojunhe suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway AT boyang suppressionofhypoxiainduciblefactor1ahif1abytirapazamineisdependentoneif2aphosphorylationratherthanthemtorc14ebp1pathway |